TransCode Therapeutics (NASDAQ:RNAZ) Announces Completion of $8 Million Private Placement
TransCode Therapeutics, a biopharmaceutical company specializing in RNA therapeutics for cancer treatment, disclosed on November 26, 2024, the completion of a significant private placement. The company entered into a securities purchase agreement with accredited investors, resulting in the sale of an aggregate of 5,710,000 shares of common stock, 15,510,160 pre-funded warrants, and 21,220,160 Series C […]
More Stories
Cybersecurity Researchers Link North Korea to $6.4 Billion Binance Hack
By Ryan Morgan Private blockchain analysis companies TRM Labs and Chainalysis have both assessed that North Korean state-backed hackers were...
US Approves Possible $2.1 Billion Sale of 500 Patriot Missiles to Ukraine
By Kimberly Hayek The State Department announced Oct. 30 that it has approved a possible sale of 500 Patriot Advanced...
Who is Timothy Busfield? Cases, Movies, Shows, and Wife
After spending several years under the allegation of child abuse charges, a New Mexico judge has finally issued a judgment....
Economic Momentum Builds as New Figures Beat Expectations
By Andrew Morand and Emel Akan The U.S. economy may be doing more than weathering recent shocks. A fresh batch...
Polish President Aborts Senegal Trip as Protests Erupt Over Court Chief’s Suspension
By Aldgra Fredly Polish President Karol Nawrocki turned back his plane on Oct. 30 while en route to Senegal after...
Judge Bars DOJ From Threatening Election Staff With Criminal Prosecution Over Ballots Processing
By Aldgra Fredly A federal judge barred the Department of Justice (DOJ) from threatening state and local election officials with...